| 869 |
Centers for Disease Control and Prevention |
Html |
en |
Avian Influenza Current Situation |
Avian Influenza Current Situation - CDC |
| avian influenza | 0.996506 |
| Asian HPAI H5N1 | 0.429876 |
| influenza antiviral drugs | 0.398262 |
| influenza A outbreaks | 0.397358 |
| Avian Influenza Detections | 0.436199 |
| HPAI | 0.521936 |
| Asian Lineage Avian | 0.411473 |
| Health Inspection Service | 0.406546 |
| pathogenic avian influenza | 0.510696 |
| asian lineage lpai | 0.443236 |
| public health risk | 0.403505 |
| Plant Health Inspection | 0.40655 |
| asian lineage hpai | 0.410347 |
| avian H5N1 viruses | 0.470538 |
| HPAI H5N6 viruses | 0.414542 |
| Avian Influenza Outbreaks | 0.455258 |
| influenza a virus | 0.426222 |
| cooking kills influenza | 0.399966 |
| LPAI avian influenza | 0.441659 |
| HPAI H7N9 viruses | 0.444718 |
| United States | 0.703177 |
| avian influenza viruses | 0.592933 |
| HPAI H5N1 virus | 0.518495 |
| lineage hpai h7n9 | 0.397356 |
|
| wild birds | 0.550726 |
| sporadic human infections | 0.417148 |
| infected poultry | 0.399284 |
| HPAI H5N8 viruses | 0.420119 |
| commercial poultry | 0.422857 |
| public health | 0.427079 |
| virus infections | 0.428699 |
| HPAI H5 viruses | 0.454053 |
| poultry | 0.569225 |
| Lineage Avian Influenza | 0.466103 |
| HPAI H5N1 viruses | 0.459532 |
| asian lineage | 0.495594 |
| LPAI H7N9 viruses | 0.407512 |
| North American lineage | 0.40808 |
| H7 virus outbreaks | 0.400966 |
| health | 0.435859 |
| Avian Influenza Portal | 0.44925 |
| human infections | 0.584898 |
| Avian Influenza Worldwide | 0.443118 |
| animal health | 0.428061 |
| information | 0.418903 |
| influenza a viruses | 0.639101 |
| commercial poultry flocks | 0.40196 |
| HPAI viruses | 0.417799 |
|
CLICK HERE |
| 4753 |
Centers for Disease Control and Prevention |
Html |
en |
Guillain-Barré Syndrome (GBS) |
Overview of Guillain Barre Sydrome GBS, what causes it, and who is at risk of developing the disorder - CDC |
| seasonal flu vaccination | 0.514995 |
| CDC | 0.346788 |
| two-thirds | 0.322789 |
| doses | 0.317265 |
| rare disorder | 0.39208 |
| United States | 0.449788 |
| respiratory illness | 0.383721 |
| Drug Administration | 0.374816 |
| Epstein Barr virus | 0.454557 |
| flu vaccine | 0.436533 |
| Page | 0.325465 |
| bacterium Campylobacter jejuni | 0.4694 |
| flu vaccines | 0.426813 |
| GBS experience symptoms | 0.78344 |
| cytomegalovirus | 0.323458 |
| infections | 0.314384 |
| GBS | 0.913695 |
| background rate | 0.376392 |
| flu seasons | 0.424412 |
| vaccine safety monitoring | 0.541912 |
|
| muscle weakness | 0.399817 |
| greatest risk | 0.376679 |
| primary systems | 0.373843 |
| paralysis | 0.319161 |
| people | 0.413547 |
| rare occasions | 0.380148 |
| diarrhea | 0.318115 |
| nerve cells | 0.399926 |
| exact cause | 0.385409 |
| Infection | 0.313871 |
| GBS increases | 0.694433 |
| Guillain-Barré syndrome | 0.394086 |
| person | 0.313468 |
| long-term nerve damage | 0.464541 |
| older adults | 0.383177 |
| difficulty breathing | 0.387784 |
| additional GBS cases | 0.734106 |
| Unites States | 0.379962 |
| rare cases | 0.383099 |
| incidence | 0.315055 |
|
CLICK HERE |
| 6538 |
Centers for Disease Control and Prevention |
Html |
en |
Keeping the U.S. Polio |
CDC Works For You 24/7 Protecting People - CDC Ramps up Support for Final Push in Global Polio Eradication Effort - On Wednesday, December 14, 2011, CDC Director Thomas R. Frieden, M.D., M.P.H., charged the entire CDC community to become active participants in an intensified strategy to eradicate polio, worldwide. The briefing followed Dr. Frieden’s December 2nd announcement activating CDC’s Emergency Operations Center for the agency’s partnership engagement through the Global Polio Eradication Initiative (GPEI). |
| polio vaccine | 0.601114 |
| United States | 0.334303 |
| Viral Diseases | 0.220937 |
| Polio control | 0.552989 |
| surveillance efforts | 0.24485 |
| polio vaccination | 0.785664 |
| worldwide eradication | 0.261025 |
| important priority | 0.220987 |
| Team Lead | 0.222589 |
| global eradication | 0.233202 |
| Sabin vaccination programs | 0.502999 |
| Epidemiology Branch | 0.22387 |
| historically high rate | 0.33691 |
| Dr. Greg Wallace | 0.323986 |
|
| remaining areas | 0.216605 |
| disease surveillance | 0.241453 |
| unvaccinated U.S. resident | 0.319143 |
| National Center | 0.219006 |
| Landmark vaccination | 0.375994 |
| CDC epidemiologists | 0.285437 |
| polio cases | 0.587519 |
| greatest risk | 0.227209 |
| continued polio vaccination | 0.748625 |
| polio | 0.934327 |
| polio transmission | 0.53974 |
| national mass Salk | 0.368992 |
| Respiratory Diseases | 0.220732 |
| Unprotected Story | 0.223748 |
|
CLICK HERE |
| 9237 |
Centers for Disease Control and Prevention |
Html |
en |
Case Count Maps | Outbreak Investigation | Cyclosporiasis | CDC |
null |
| area | 0.258512 |
| cases | 0.921685 |
| Cyclospora infection | 0.755994 |
| Data | 0.666556 |
| Minnesota | 0.200877 |
| Kansas | 0.256169 |
| New Jersey | 0.644916 |
| Nebraska | 0.25781 |
| states | 0.204876 |
| New York City | 0.626829 |
| number | 0.258775 |
|
| international travel-associated cases | 0.558083 |
| total | 0.478497 |
| Iowa | 0.258007 |
| EDT | 0.297573 |
| Texas | 0.258292 |
| Illinois | 0.257172 |
| Connecticut | 0.255452 |
| Ohio | 0.201239 |
| Georgia | 0.25653 |
| state | 0.22129 |
|
CLICK HERE |
| 10176 |
Centers for Disease Control and Prevention |
Html |
es |
Congelamiento|Temporada invernal |
Tomar medidas preventivas es su mejor protección contra las temperaturas frías extremas. Usted puede reducir el riesgo de sufrir afecciones atribuidas a las condiciones climáticas si prepara su casa y auto con antelación para las emergencias de invierno y si toma precauciones de seguridad durante las temperaturas extremadamente frías. |
| siguientes recomendaciones | 0.50463 |
| Archivo Apple Quicktime | 0.602994 |
| Archivo Zip Comprimido | 0.598955 |
| siguientes signos | 0.511088 |
| busque atención | 0.741234 |
|
| Archivo Microsoft PowerPoint | 0.628558 |
| Archivo Adobe PDF | 0.601548 |
| Archivo Microsoft Excel | 0.600594 |
| almohadillas calefactoras | 0.498109 |
| Archivo Microsoft | 0.937578 |
|
CLICK HERE |
| 10595 |
Centers for Disease Control and Prevention |
Html |
en |
Mental Health Basics - Mental Health |
null |
| common type | 0.561667 |
| U.S. adult population.3 | 0.614737 |
| Health Services Administration | 0.645576 |
| equitable jobs | 0.558162 |
| mental health | 0.993118 |
| ischemic heart disease | 0.620773 |
| Human Services | 0.597993 |
| personal self-worth | 0.562429 |
| Prev Chronic Dis | 0.609199 |
| risk behaviors | 0.55942 |
| Arch Gen Psychiatry | 0.597373 |
| general health | 0.60107 |
| U.S. Department | 0.59825 |
| social determinants | 0.606017 |
| term mental health | 0.715604 |
| health outcomes | 0.610841 |
| National Comorbidity Survey | 0.611356 |
| social acceptance | 0.56084 |
| depressive disorders | 0.617243 |
| health conditions | 0.605965 |
| life satisfaction | 0.557637 |
| normal stresses | 0.563684 |
| World Health Organization | 0.815959 |
| mental illness | 0.810801 |
| public health arena | 0.650328 |
|
| 12-month DSM-IV disorders | 0.613175 |
| insufficient sleep | 0.560921 |
| different psychological states | 0.623855 |
| chronic disease | 0.61158 |
| Social well–being | 0.560671 |
| quality health care | 0.647281 |
| Soc Psychol Quart | 0.615651 |
| successful treatment | 0.558045 |
| mental health promotion | 0.753692 |
| diagnosable mental disorders | 0.659993 |
| quality education | 0.557883 |
| TW.The vital link | 0.596242 |
| Chiu WT | 0.558557 |
| excessive drinking | 0.557398 |
| National Institute | 0.557137 |
| cardiovascular disease | 0.564568 |
| chronic diseases | 0.566377 |
| positive mental health | 0.709858 |
| adequate housing | 0.558354 |
| Pers Soc Psychol | 0.69158 |
| U.S adults | 0.565876 |
| optimal mental health.2 | 0.662232 |
| surgeon general notes | 0.607866 |
| Mental Health Services | 0.715276 |
|
CLICK HERE |
| 11431 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Characteristics of the Built Environment in Relation to Objectively Measured Physical Activity Among Mexican Adults, 2011 - CDC |
The built environment correlates of physical activity are documented in high-income countries but have yet to be studied among Mexican adults. Our objectives were to assess the associations between characteristics of the built environment and physical activity among adults in Cuernavaca, Mexico, and to examine potential moderation by perceived park and neighborhood safety. |
| self-reported physical activity | 0.557004 |
| public bus routes | 0.566655 |
| walkability index | 0.599203 |
| study | 0.55783 |
| high-income countries | 0.729506 |
| weekly physical activity | 0.558094 |
| residential density | 0.630778 |
| home visit | 0.569273 |
| environment correlates | 0.553631 |
| geographic information systems | 0.561673 |
| association | 0.554716 |
| park safety | 0.589305 |
| high crime rates | 0.557622 |
| physical activity domains | 0.554106 |
| transit routes | 0.557601 |
| parks | 0.587714 |
| number | 0.565041 |
| public health implications | 0.552764 |
| 500-m buffer | 0.740484 |
| buffer area/total buffer | 0.594059 |
| moderate-to-vigorous physical activity | 0.590458 |
| Mexican National Institute | 0.554989 |
| total MVPA | 0.800242 |
| US-based walkability index | 0.561286 |
|
| 10-minute bouts | 0.558559 |
| bouts | 0.61303 |
| public health | 0.572592 |
| corresponding 500-m buffer | 0.569901 |
| National Institute | 0.56432 |
| neighborhood safety | 0.558497 |
| low-to-middle income countries | 0.604932 |
| safety perception | 0.587657 |
| Cuernavaca | 0.565712 |
| Mexican adults | 0.562581 |
| physical activity outcome | 0.558799 |
| International Physical Activity | 0.563087 |
| net residential density | 0.621922 |
| 1-km buffer | 0.647318 |
| physical activity | 0.971529 |
| land-use mix | 0.625224 |
| park safety perception | 0.557511 |
| commercial land | 0.55918 |
| environment | 0.598284 |
| leisure-time physical activity | 0.555325 |
| Mexico | 0.563191 |
| linear regression models | 0.578967 |
| linear trend | 0.562041 |
|
CLICK HERE |
| 11749 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Community-Based Interventions to Improve Outcomes for Cardiovascular Disease [Letter] - CDC |
We applaud Oldenburg and colleagues for the successful implementation of a community-based intervention to curtail cardiovascular disease |
| heart attack | 0.388478 |
| various meta-analyses | 0.385284 |
| major CVD events | 0.553799 |
| modest increases | 0.37716 |
| primary CVD prevention | 0.592897 |
| slight reduction | 0.397864 |
| post-AMI mortality | 0.397688 |
| myocardial infarction | 0.386049 |
| Jackson Memorial Hospital | 0.439004 |
| Drug Administration | 0.383095 |
| hemorrhagic stroke | 0.380647 |
| successful implementation | 0.387602 |
| Bayer Healthcare | 0.383746 |
| clinical outcomes | 0.386054 |
| primary prevention | 0.909215 |
| aspirin | 0.77426 |
| Oldenburg | 0.386812 |
| aspirin therapy | 0.5869 |
| increased risk | 0.393602 |
| Preventive Services Task | 0.607494 |
| lesser role | 0.376787 |
| cardiovascular disease | 0.390721 |
| better risk-to-benefit profile | 0.440778 |
| potential success | 0.373817 |
|
| secondary prevention | 0.385729 |
| Kyle A. Davis | 0.428959 |
| community-based program | 0.382683 |
| absolute risk reduction | 0.476309 |
| Services Task Force | 0.605774 |
| absolute reduction | 0.434745 |
| adverse events | 0.427423 |
| atherosclerotic events | 0.388789 |
| statin therapy | 0.464453 |
| gastrointestinal bleeding | 0.381804 |
| CVD | 0.638067 |
| community-based interventions | 0.376896 |
| negative CVD outcomes | 0.572003 |
| intracranial hemorrhage | 0.381002 |
| low-dose aspirin | 0.573509 |
| statins | 0.421884 |
| patient factors | 0.377495 |
| colleagues | 0.45022 |
| all-cause mortality | 0.408883 |
| Marta A. Miyares | 0.433022 |
| community-based intervention | 0.399903 |
| confidence interval | 0.383975 |
| modest improvement | 0.383814 |
|
CLICK HERE |
| 13788 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Poliomyelitis Eradication - Afghanistan,January 2014-August 2015 |
Chukwuma Mbaeyi, DDS1; Akif Saatcioglu, MD2; Rudolf H. Tangermann, MD2; Stephen Hadler, MD3; Derek Ehrhardt, MPH, MSN1. |
| global polio eradication | 0.826552 |
| supplementary immunization activities | 0.580868 |
| Kandahar Province | 0.546287 |
| poliovirus transmission | 0.636747 |
| vaccination campaigns | 0.596797 |
| sewage samples | 0.584346 |
| environmental surveillance | 0.580545 |
| Emergency Action Plan | 0.753996 |
| SIAs | 0.719414 |
| AFP cases | 0.542671 |
| polio eradication activities | 0.862633 |
| Eastern Region | 0.595945 |
| children | 0.832941 |
| routine immunization | 0.845623 |
| conflict-affected Southern Region | 0.57299 |
| national Polio Eradication | 0.661483 |
| WPV1 cases | 0.819141 |
| National Emergency Action | 0.752899 |
| routine immunization services | 0.675453 |
| Chukwuma Mbaeyi | 0.540545 |
| Polio Eradication Initiative | 0.727008 |
| Farah Province | 0.60043 |
| World Health Organization | 0.600062 |
| polio cases | 0.562834 |
|
| critical regions | 0.542065 |
| house-to-house SIAs | 0.554133 |
| indigenous poliovirus transmission | 0.595109 |
| 1Global Immunization Division | 0.544626 |
| polio transmission | 0.556916 |
| national routine vaccination | 0.573691 |
| routine immunization coverage | 0.561982 |
| Afghanistan | 0.697213 |
| regions | 0.600561 |
| Eastern regions | 0.542605 |
| polio eradication | 0.995973 |
| oral poliovirus vaccine | 0.776839 |
| permanent polio teams | 0.572634 |
| supervise SIAs | 0.567068 |
| routine OPV3 coverage | 0.550888 |
| national polio EOC | 0.584005 |
| Polio Eradication Department | 0.6044 |
| Southern Region | 0.881854 |
| Western Region | 0.714805 |
| permanent transit teams | 0.610842 |
| routine immunization activities | 0.56436 |
| accessible areas | 0.678487 |
| acute flaccid paralysis | 0.652692 |
| Global Polio Laboratory | 0.571606 |
|
CLICK HERE |
| 16316 |
Centers for Disease Control and Prevention |
Html |
en |
FastStats - Body Measurements |
null |
| tables | 0.350139 |
| PDF | 0.346959 |
| United States | 0.616413 |
| MB | 0.427276 |
|
| Adults | 0.351851 |
| Children | 0.35234 |
| Anthropometric Reference Data | 0.95397 |
|
CLICK HERE |